Assessing in vitro and in vivo oncogenicity and tumorigenicity of cellular DNA
$389,600Y01FY2011AINIH
National Institute Of Allergy And Infectious Diseases
Investigators
Abstract
This IAA supports the development of in vivo animal models and in vitro assays that will allow a better assessment of the overall safety of vaccines and vaccine formulations, including a better understanding of the oncogenic potential of cell substrates, and better tools to screen for adventitious agents in cell substrates.
View original record on NIH RePORTER →